Sanofi India is currently trading at Rs. 6413.30, up by 43.50 points or 0.68% from its previous closing of Rs. 6369.80 on the BSE.
The scrip opened at Rs. 6350.00 and has touched a high and low of Rs. 6445.00 and Rs. 6350.00 respectively. So far 92 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 6840.05 on 10-Sep-2018 and a 52 week low of Rs. 4675.00 on 22-Jan-2018.
Last one week high and low of the scrip stood at Rs. 6445.00 and Rs. 6155.00 respectively. The current market cap of the company is Rs. 14770.23 crore.
The promoters holding in the company stood at 60.40%, while Institutions and Non-Institutions held 29.07% and 10.54% respectively.
Sanofi India has launched the new advertisement campaign for their topical analgesic - Combiflam ICYHOT to provide effective relief to people suffering from strong pains.
The film conceptualized by Ogilvy, is a clutter breaking advertisement with humorous undertones that is bringing smiles on the face of viewers. The advertisement campaign was developed on the insight that pain can weigh one down and can derail one’s day to day life. Effective respite from pain can help people get back on track and move forward.
Sanofi, a global and diversified healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, rare diseases, consumer healthcare, emerging markets and animal health.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |